Indeed, in vitro switch of TA to ALT activity in telomerase-positive cancer cells was successfully demonstrated by inducing telomere-specific DNA damage, ATRX and DAXX knockdown, and deletion of hTERT [58]. The gene discussed is ATRX; the disease is cancer.